{"id":"https://openalex.org/W3142792508","doi":"https://doi.org/10.3803/enm.2020.818","title":"Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis","display_name":"Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis","alternate_titles":[],"publication_year":2021,"publication_date":"2021-04-06","ids":{"openalex":"https://openalex.org/W3142792508","doi":"https://doi.org/10.3803/enm.2020.818","mag":"3142792508","pmid":"https://pubmed.ncbi.nlm.nih.gov/33820392","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8090470"},"language":"en","primary_location":{"id":"doi:10.3803/enm.2020.818","doi":"https://doi.org/10.3803/enm.2020.818","is_oa":true,"landing_page_url":"https://doi.org/10.3803/enm.2020.818","pdf_url":"https://www.e-enm.org/upload/pdf/enm-2020-818.pdf","source":{"id":"https://openalex.org/S191829013","display_name":"Endocrinology and Metabolism","issn_l":"2093-596X","issn":["2093-596X","2093-5978"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","kci-registered","ki-jl-1","medline","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319498","host_organization_name":"Academya Publishing Co.","host_organization_lineage":["https://openalex.org/P4310319498"],"host_organization_lineage_names":["Academya Publishing Co."],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrinology and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3142792508"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.e-enm.org/upload/pdf/enm-2020-818.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069401358","display_name":"Deep Dutta","orcid":"https://orcid.org/0000-0003-4915-8805","observed_orcids":["https://orcid.org/0000-0003-4915-8805"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Deep Dutta","raw_affiliation_strings":["Department of Endocrinology, Center for Endocrinology, Diabetes, Arthritis & Rheumatism (CEDAR) Superspeciality Clinics, New Delhi, India"],"raw_orcid":"https://orcid.org/0000-0003-4915-8805","affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Center for Endocrinology, Diabetes, Arthritis & Rheumatism (CEDAR) Superspeciality Clinics, New Delhi, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110414467","display_name":"Anshita Aggarwal","orcid":"https://orcid.org/0000-0002-6969-2530","observed_orcids":["https://orcid.org/0000-0002-6969-2530","https://orcid.org/0000-0002-9241-3683"]},"institutions":[{"id":"https://openalex.org/I2800585909","display_name":"Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital","ror":"https://ror.org/00qa63322","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I2800585909"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anshita Agarwal","raw_affiliation_strings":["Department of Endocrinology, Dr Ram Manohar Lohia (RML) Hospital, New Delhi, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Dr Ram Manohar Lohia (RML) Hospital, New Delhi, India","institution_ids":["https://openalex.org/I2800585909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004279785","display_name":"Indira Maisnam","orcid":"https://orcid.org/0000-0002-4674-7906","observed_orcids":["https://orcid.org/0000-0002-4674-7906"]},"institutions":[{"id":"https://openalex.org/I336022086","display_name":"R. G. Kar Medical College and Hospital","ror":"https://ror.org/05fyf7995","country_code":"IN","type":"education","lineage":["https://openalex.org/I226431899","https://openalex.org/I336022086"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Indira Maisnam","raw_affiliation_strings":["Department of Endocrinology, R G Kar Medical College, Calcutta, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, R G Kar Medical College, Calcutta, India","institution_ids":["https://openalex.org/I336022086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062401606","display_name":"Rajiv Singla","orcid":"https://orcid.org/0000-0002-9674-6872","observed_orcids":["https://orcid.org/0000-0002-9674-6872"]},"institutions":[{"id":"https://openalex.org/I4210148176","display_name":"Kalpavriksh","ror":"https://ror.org/04c5nsm37","country_code":"IN","type":"nonprofit","lineage":["https://openalex.org/I4210148176"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rajiv Singla","raw_affiliation_strings":["Department of Endocrinology, Kalpavriksh Healthcare, Dwarka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Kalpavriksh Healthcare, Dwarka, India","institution_ids":["https://openalex.org/I4210148176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107877444","display_name":"Deepak Khandelwal","orcid":"https://orcid.org/0000-0002-8185-8206","observed_orcids":["https://orcid.org/0000-0002-8185-8206"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Deepak Khandelwal","raw_affiliation_strings":["Department of Endocrinology, Maharaja Agrasen Hospital, New Delhi, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Maharaja Agrasen Hospital, New Delhi, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038214431","display_name":"Meha Sharma","orcid":"https://orcid.org/0000-0003-0249-2523","observed_orcids":["https://orcid.org/0000-0003-0249-2523"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Meha Sharma","raw_affiliation_strings":["Department of Rheumatology, Center for Endocrinology, Diabetes, Arthritis & Rheumatism (CEDAR) Superspeciality Clinics, New Delhi, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Center for Endocrinology, Diabetes, Arthritis & Rheumatism (CEDAR) Superspeciality Clinics, New Delhi, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5069401358"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1804,"has_fulltext":true,"cited_by_count":42,"citation_normalized_percentile":{"value":0.77847072,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"36","issue":"2","first_page":"374","last_page":"387"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemigliptin","display_name":"gemigliptin","score":1.0},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9580000042915344},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9950000047683716},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8740000128746033},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9010000228881836},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5979999899864197},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.5519999861717224},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.6039999723434448},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4569999873638153},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.5569999814033508},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.9160000085830688},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.9909999966621399},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.9890000224113464},{"id":"https://openalex.org/keywords/rosuvastatin","display_name":"rosuvastatin","score":0.8009999990463257},{"id":"https://openalex.org/keywords/glycemic-targets","display_name":"glycemic targets","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8085092306137085},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.6950148940086365},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6570329666137695},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.6141273379325867},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5830171704292297},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.5648611187934875},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5397698879241943},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5339675545692444},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5252760648727417},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5109156966209412},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.4343652129173279},{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.42972898483276367},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4227978587150574},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38886889815330505},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.28010302782058716},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.21726953983306885},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004152","descriptor_name":"Dipeptidyl-Peptidases and Tripeptidyl-Peptidases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010881","descriptor_name":"Piperidones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3803/enm.2020.818","doi":"https://doi.org/10.3803/enm.2020.818","is_oa":true,"landing_page_url":"https://doi.org/10.3803/enm.2020.818","pdf_url":"https://www.e-enm.org/upload/pdf/enm-2020-818.pdf","source":{"id":"https://openalex.org/S191829013","display_name":"Endocrinology and Metabolism","issn_l":"2093-596X","issn":["2093-596X","2093-5978"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","kci-registered","ki-jl-1","medline","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319498","host_organization_name":"Academya Publishing Co.","host_organization_lineage":["https://openalex.org/P4310319498"],"host_organization_lineage_names":["Academya Publishing Co."],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrinology and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8090470","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8090470/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrinol Metab (Seoul)","raw_type":"Text"},{"id":"pmid:33820392","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33820392","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrinology and metabolism (Seoul, Korea)","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:777eba46222042b281814ae2e070e165","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/777eba46222042b281814ae2e070e165","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Endocrinology and Metabolism, Vol 36, Iss 2, Pp 374-387 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3803/enm.2020.818","doi":"https://doi.org/10.3803/enm.2020.818","is_oa":true,"landing_page_url":"https://doi.org/10.3803/enm.2020.818","pdf_url":"https://www.e-enm.org/upload/pdf/enm-2020-818.pdf","source":{"id":"https://openalex.org/S191829013","display_name":"Endocrinology and Metabolism","issn_l":"2093-596X","issn":["2093-596X","2093-5978"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","kci-registered","ki-jl-1","medline","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319498","host_organization_name":"Academya Publishing Co.","host_organization_lineage":["https://openalex.org/P4310319498"],"host_organization_lineage_names":["Academya Publishing Co."],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrinology and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3142792508.pdf","grobid_xml":"https://content.openalex.org/works/W3142792508.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1526504767","https://openalex.org/W1973037639","https://openalex.org/W2011415835","https://openalex.org/W2069121805","https://openalex.org/W2088009623","https://openalex.org/W2098923148","https://openalex.org/W2128783945","https://openalex.org/W2134833483","https://openalex.org/W2165010366","https://openalex.org/W2165463543","https://openalex.org/W2170003639","https://openalex.org/W2409008856","https://openalex.org/W2519704960","https://openalex.org/W2523117066","https://openalex.org/W2561612220","https://openalex.org/W2566141468","https://openalex.org/W2582931416","https://openalex.org/W2588681363","https://openalex.org/W2599340633","https://openalex.org/W2603386412","https://openalex.org/W2736794838","https://openalex.org/W2770376393","https://openalex.org/W2791560436","https://openalex.org/W2885994976","https://openalex.org/W2950576625","https://openalex.org/W2971541999","https://openalex.org/W2972534878"],"related_works":["https://openalex.org/W2561612220","https://openalex.org/W1973037639","https://openalex.org/W2170003639","https://openalex.org/W4382358644","https://openalex.org/W2808742729","https://openalex.org/W2971541999","https://openalex.org/W3102822520","https://openalex.org/W4391143790","https://openalex.org/W1994832750","https://openalex.org/W2519704960"],"abstract_inverted_index":{"BACKGROUND:":[0],"No":[1],"meta-analysis":[2,19],"has":[3,253],"holistically":[4],"analysed":[5],"and":[6,10,43,71,218,257],"summarised":[7],"the":[8,40,47,94,216],"efficacy":[9,256],"safety":[11],"of":[12,134,152,263],"gemigliptin":[13,38,111,217,234],"in":[14,39,46,55,64],"type":[15],"2":[16],"diabetes.":[17],"The":[18,50,59,233],"addresses":[20],"this":[21],"knowledge":[22],"gap.":[23],"METHODS:":[24],"Electronic":[25],"databases":[26],"were":[27,62,82,213],"searched":[28],"for":[29],"randomised":[30],"controlled":[31],"trials":[32],"(RCTs)":[33],"involving":[34,79],"diabetes":[35],"patients":[36,81],"receiving":[37],"intervention":[41],"arm":[42],"placebo/active":[44],"comparator":[45],"control":[48,88,101,219],"arm.":[49],"primary":[51],"outcome":[52],"was":[53,115,156,190],"change":[54],"haemoglobin":[56],"A1c":[57],"(HbA1c).":[58],"secondary":[60],"outcomes":[61],"alterations":[63],"glucose,":[65],"glycaemic":[66,255],"targets,":[67],"lipids,":[68],"insulin":[69],"resistance,":[70],"adverse":[72],"events.":[73],"RESULTS:":[74],"Data":[75],"from":[76],"10":[77],"RCTs":[78],"1,792":[80],"analysed.":[83],"Four":[84],"had":[85,98],"an":[86],"active":[87,95],"group":[89,102,235],"(ACG),":[90],"with":[91,104],"metformin/dapagliflozin/sitagliptin/glimepiride":[92],"as":[93,106],"comparator;":[96],"six":[97],"a":[99],"passive":[100],"(PCG),":[103],"placebo/rosuvastatin":[105],"controls.":[107],"HbA1c":[108,162,196],"reduction":[109],"by":[110],"at":[112],"24":[113,177,199],"weeks":[114,200],"comparable":[116,191],"to":[117,128,139,146,158,173,184,192,206,228,246],"ACG":[118,193],"(mean":[119],"difference":[120],"[MD],":[121],"0.09%;":[122],"95%":[123,143,170,181,203,225,243],"confidence":[124],"interval":[125],"[CI],":[126],"-0.06":[127],"0.23;":[129],"P=0.24;":[130],"I2=0%;":[131],"moderate":[132],"certainty":[133,151],"evidence":[135,153],"[MCE]),":[136],"but":[137],"superior":[138,157],"PCG":[140,159],"(MD,":[141],"-0.91%;":[142],"CI,":[144,171,182,204,226,244],"-1.18":[145],"-0.63);":[147],"P<0.01;":[148,186],"I2=89%;":[149],"high":[150],"[HCE]).":[154],"Gemigliptin":[155,189,252],"regarding":[160,194],"achieving":[161,195],"<7%":[163,197],"(12":[164],"weeks:":[165,178],"odds":[166],"ratio":[167,222],"[OR],":[168],"5.91;":[169],"1.34":[172],"26.08;":[174],"P=0.02;":[175],"I2=74%;":[176],"OR,":[179],"4.48;":[180],"2.09":[183],"9.60;":[185],"I2=69%;":[187],"HCE).":[188,232,250],"after":[198],"(OR,":[201],"0.92;":[202],"0.52":[205],"1.63;":[207],"P=0.77;":[208],"I2=66%;":[209],"MCE).":[210],"Adverse":[211],"events":[212],"similar":[214],"between":[215],"groups":[220],"(risk":[221],"[RR],":[223],"1.06;":[224],"0.82":[227],"1.36;":[229],"P=0.66;":[230],"I2=35%;":[231],"did":[236],"not":[237],"have":[238],"increased":[239],"hypoglycaemia":[240],"(RR,":[241],"1.19;":[242],"0.62":[245],"2.28;":[247],"P=0.61;":[248],"I2=19%;":[249],"CONCLUSION:":[251],"good":[254],"is":[258],"well-tolerated":[259],"over":[260],"6":[261],"months":[262],"use.":[264]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3142792508","counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2021-04-13T00:00:00"}
